Search Results - Elena A. Govorkova

Refine Results
  1. 1
    H5N1 Influenza — Continuing Evolution and Spread

    H5N1 Influenza — Continuing Evolution and Spread by Robert G. Webster, Elena A. Govorkova

    Published 2006
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  2. 2
    Combination Chemotherapy for Influenza

    Combination Chemotherapy for Influenza by Elena A. Govorkova, Robert G. Webster

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Continuing challenges in influenza

    Continuing challenges in influenza by Robert G. Webster, Elena A. Govorkova

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistance

    Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistance by Andrew J. Burnham, Tatiana Baranovich, Elena A. Govorkova

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Virulence May Determine the Necessary Duration and Dosage of Oseltamivir Treatment for Highly Pathogenic A/Vietnam/1203/04 Influenza Virus in Mice

    Virulence May Determine the Necessary Duration and Dosage of Oseltamivir Treatment for Highly Pathogenic A/Vietnam/1203/04 Influenza Virus in Mice by Hui‐Ling Yen, Arnold S. Monto, Robert G. Webster, Elena A. Govorkova

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells

    Neuraminidase Inhibitor-Rimantadine Combinations Exert Additive and Synergistic Anti-Influenza Virus Effects in MDCK Cells by Elena A. Govorkova, Hong‐Bin Fang, Ming Tan, Robert G. Webster

    Published 2004
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Drugs in Development for Influenza

    Drugs in Development for Influenza by David A. Boltz, Jerry R. Aldridge, Robert G. Webster, Elena A. Govorkova

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Amantadine-Oseltamivir Combination therapy for H5N1 Influenza Virus Infection in Mice

    Amantadine-Oseltamivir Combination therapy for H5N1 Influenza Virus Infection in Mice by Natalia A. Ilyushina, Erich Hoffmann, Rachelle Salomon, Robert G. Webster, Elena A. Govorkova

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Determination of Neuraminidase Kinetic Constants Using Whole Influenza Virus Preparations and Correction for Spectroscopic Interference by a Fluorogenic Substrate

    Determination of Neuraminidase Kinetic Constants Using Whole Influenza Virus Preparations and Correction for Spectroscopic Interference by a Fluorogenic Substrate by Bindumadhav M. Marathe, Vincent Lévêque, Klaus Klumpp, Robert G. Webster, Elena A. Govorkova

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines

    Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines by Erich Hoffmann, Aleksandr S. Lipatov, Richard J. Webby, Elena A. Govorkova, Robert G. Webster

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses

    Comparison of Efficacies of RWJ-270201, Zanamivir, and Oseltamivir against H5N1, H9N2, and Other Avian Influenza Viruses by Elena A. Govorkova, Irina A. Leneva, Olga Goloubeva, Karen Bush, Robert G. Webster

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses

    African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses by Elena A. Govorkova, Gopal Murti, Bernard Meignier, C. de Taisne, Robert G. Webster

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Influenza antivirals and their role in pandemic preparedness

    Influenza antivirals and their role in pandemic preparedness by Jeremy C. Jones, Hui‐Ling Yen, Peter Adams, Kimberly L. Armstrong, Elena A. Govorkova

    Published 2022
    Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Effect of Neuraminidase Inhibitor–Resistant Mutations on Pathogenicity of Clade 2.2 A/Turkey/15/06 (H5N1) Influenza Virus in Ferrets

    Effect of Neuraminidase Inhibitor–Resistant Mutations on Pathogenicity of Clade 2.2 A/Turkey/15/06 (H5N1) Influenza Virus in Ferrets by Natalia A. Ilyushina, Jon P. Seiler, Jerold E. Rehg, Robert G. Webster, Elena A. Govorkova

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Novel Roles of Focal Adhesion Kinase in Cytoplasmic Entry and Replication of Influenza A Viruses

    Novel Roles of Focal Adhesion Kinase in Cytoplasmic Entry and Replication of Influenza A Viruses by Husni Elbahesh, Troy Cline, Tatiana Baranovich, Elena A. Govorkova, Stacey Schultz‐Cherry, Charles J. Russell

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors

    Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors by Konstantin Andreev, Jeremy C. Jones, Patrick Seiler, Ahmed Kandeil, Richard J. Webby, Elena A. Govorkova

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Fitness Costs for Influenza B Viruses Carrying Neuraminidase Inhibitor-Resistant Substitutions: Underscoring the Importance of E119A and H274Y

    Fitness Costs for Influenza B Viruses Carrying Neuraminidase Inhibitor-Resistant Substitutions: Underscoring the Importance of E119A and H274Y by Andrew J. Burnham, Tatiana Baranovich, Bindumadhav M. Marathe, Jianling Armstrong, Robert G. Webster, Elena A. Govorkova

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Neuraminidase Inhibitor-Resistant Recombinant A/Vietnam/1203/04 (H5N1) Influenza Viruses Retain Their Replication Efficiency and Pathogenicity In Vitro and In Vivo

    Neuraminidase Inhibitor-Resistant Recombinant A/Vietnam/1203/04 (H5N1) Influenza Viruses Retain Their Replication Efficiency and Pathogenicity In Vitro and In Vivo by Hui‐Ling Yen, Natalia A. Ilyushina, Rachelle Salomon, Erich Hoffmann, Robert G. Webster, Elena A. Govorkova

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Efficacy of Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1 Influenza Virus

    Efficacy of Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1 Influenza Virus by Elena A. Govorkova, Natalia A. Ilyushina, David A. Boltz, Alan Douglas, Neziha Yılmaz, Robert G. Webster

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice

    Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice by Natalia A. Ilyushina, Alan Hay, Neziha Yılmaz, Adrianus C. M. Boon, Robert G. Webster, Elena A. Govorkova

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: